Ondansetron is a widely used anti-emetic for managing nausea and vomiting caused by chemotherapy, gastroenteritis, motion sickness, and morning sickness. Traditional formulations include dispersible tablets, syrups, and injections, but these can be challenging for pediatric patients due to the bitter taste of ondansetron. To enhance palatability and patient compliance, we propose the development of a novel dosage form: ondansetron-infused chocolate. This innovative approach leverages chocolate’s natural appeal to pediatric patients, effectively masking the drug’s bitterness. By utilizing a chocolate base, we aim to improve the acceptability of ondansetron, thereby ensuring better adherence to treatment regimens. This chocolate drug delivery system represents a versatile and child-friendly technology, potentially transforming how pediatric anti-emetic therapy is administered.
No takes yet. Share an insight, caveat, or question.
Qureshi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: